Clonidine
Duraclon, Nexiclon XR, ONYDA XR
Central alpha-2 Adrenergic Agonist
NADAC/unit
$0.0251
No Shortage
Tier 1: 342.9%
PA Req: 1.8%
23 Manufacturers
51 ANDAs
INDICATIONS AND USAGE Clonidine hydrochloride tablets are indicated in the treatment of hypertension.
vs. brand Duraclon: Generic saves up to 100% per unit
Generic Manufacturers
ACTAVIS ELIZABETH LLCACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCACTAVIS LABORATORIES UT INCAJANTA PHARMA LTDALEMBIC PHARMACEUTICALS LTDATHENA BIOSCIENCE LLCAUROBINDO PHARMA LTDAZURITY PHARMACEUTICALS INCCHARTWELL MOLECULES LLCCHARTWELL RX SCIENCES LLCDR REDDYS LABORATORIES SAFRESENIUS KABI USA LLCHIKMA FARMACEUTICA (PORTUGAL) SAIMPAX LABORATORIES INCJUBILANT GENERICS LTDLAVIPHARM SAMYLAN INSTITUTIONAL LLCMYLAN TECHNOLOGIES INCNOVAST LABORATORIES LTDPRINSTON PHARMACEUTICAL INCSOMERSET THERAPEUTICS LLCTP ANDA HOLDINGS LLCTRIS PHARMA INCUNICHEM LABORATORIES LTDXGEN PHARMACEUTICALS DJB INCXIAMEN LP PHARMACUETICAL CO LTDYUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
